Broad Institute

We are a research organization dedicated to better understanding the roots of disease and narrowing the gap between new biological insights and impact for patients. We are committed to characterizing psychiatric disorders' molecular roots and turning new findings into new treatments. We are fostering a diverse research community engaged in innovative chemical biology and therapeutic research. The mission of the Broad Institute of MIT and Harvard is to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals. Based in Cambridge, Massachusetts, the Broad Institute was founded in 2004 to fulfill the promise of genomic medicine—three years after completion of the Human Genome Project, which Broad scientists helped create and lead. Our researchers are deeply collaborative, nimbly launching innovative, high-risk projects at every scale, gaining insight into the biological mechanisms of disease, inventing new technologies, building and implementing computational tools, developing new therapeutics to advance into the clinic, mentoring and training the next generation of scientists, and sharing our data and tools openly to enable breakthroughs anywhere. We work with researchers and patients to tackle important challenges in biomedicine and find innovative, high-impact solutions.